ATE239457T1 - Verfahren zur prophylaktischen behandlung von mastitis - Google Patents

Verfahren zur prophylaktischen behandlung von mastitis

Info

Publication number
ATE239457T1
ATE239457T1 AT98963702T AT98963702T ATE239457T1 AT E239457 T1 ATE239457 T1 AT E239457T1 AT 98963702 T AT98963702 T AT 98963702T AT 98963702 T AT98963702 T AT 98963702T AT E239457 T1 ATE239457 T1 AT E239457T1
Authority
AT
Austria
Prior art keywords
mastitis
prophylactic treatment
prophylactic
treatment
Prior art date
Application number
AT98963702T
Other languages
English (en)
Inventor
Ake Lignell
Johan Inborr
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Application granted granted Critical
Publication of ATE239457T1 publication Critical patent/ATE239457T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
AT98963702T 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis ATE239457T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
PCT/SE1998/002279 WO1999030701A1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis

Publications (1)

Publication Number Publication Date
ATE239457T1 true ATE239457T1 (de) 2003-05-15

Family

ID=20409414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98963702T ATE239457T1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis

Country Status (12)

Country Link
US (1) US6335015B1 (de)
EP (1) EP1049460B1 (de)
JP (1) JP2002508318A (de)
AR (1) AR017877A1 (de)
AT (1) ATE239457T1 (de)
AU (1) AU743198B2 (de)
CA (1) CA2314170C (de)
DE (1) DE69814467D1 (de)
NO (1) NO327301B1 (de)
NZ (1) NZ504801A (de)
SE (1) SE511237C2 (de)
WO (1) WO1999030701A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
AU2003256982A1 (en) 2002-07-29 2004-02-16 Cardax Pharmaceuticals, Inc. Structural carotenoid analogs for the inhibition and amelioration of disease
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
EP1750723A1 (de) 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid-analoga oder derivate zur hemmung und linderung von entzündungen
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
DK1806982T3 (en) 2004-09-28 2018-11-19 Avivagen Inc COMPOSITIONS AND PROCEDURES FOR PROMOTING WEIGHT ADMINISTRATION AND FOOD TRAFFIC
US7247752B2 (en) 2004-10-01 2007-07-24 Cardax Pharmaceuticals, Inc. Methods for the synthesis of astaxanthin
PL2214656T3 (pl) 2007-10-26 2019-06-28 Avivagen Inc. Kompozycje i sposoby wzmacniania odpowiedzi immunologicznej
WO2010124392A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods, compositions, and kits for the treatment of inflammatory conditions
CA2771204C (en) 2009-04-30 2017-09-19 Chemaphor Inc. Methods and compositions for improving the health of animals
JP2023513835A (ja) * 2020-02-18 2023-04-03 アヴィヴァジェン インコーポレーテッド 哺乳類のための補充された動物飼料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
EP0806946A2 (de) * 1995-02-03 1997-11-19 Basf Aktiengesellschaft Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE506191C2 (sv) * 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur

Also Published As

Publication number Publication date
DE69814467D1 (de) 2003-06-12
NO20003042L (no) 2000-06-14
NZ504801A (en) 2002-05-31
AU1897299A (en) 1999-07-05
US6335015B1 (en) 2002-01-01
NO20003042D0 (no) 2000-06-14
EP1049460A1 (de) 2000-11-08
NO327301B1 (no) 2009-06-02
SE511237C2 (sv) 1999-08-30
JP2002508318A (ja) 2002-03-19
WO1999030701A1 (en) 1999-06-24
CA2314170C (en) 2008-01-29
CA2314170A1 (en) 1999-06-24
AU743198B2 (en) 2002-01-24
EP1049460B1 (de) 2003-05-07
SE9704693D0 (sv) 1997-12-16
AR017877A1 (es) 2001-10-24
SE9704693L (sv) 1999-06-17

Similar Documents

Publication Publication Date Title
ATE239457T1 (de) Verfahren zur prophylaktischen behandlung von mastitis
DE69806970T2 (de) Verfahren zur behandlung von hartgeweben
DE69603838D1 (de) Verfahren zur behandlung von gasen
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
DE69624116D1 (de) Verfahren zur behandlung von allergischem asthma
DE69701714T2 (de) Verfahren zur behandlung von glassubstraten
DE69710422D1 (de) Verfahren zur Behandlung von Polyethern vor Hydrosilylation
DE69714828D1 (de) Verfahren zur Behandlung von Abfallstoffen
DE59810532D1 (de) Verfahren zur behandlung von cellulosischen formkörpern
DE69702997D1 (de) Verfahren zur Behandlung von verunreinigtem Aluminiumoxid
DE69937624D1 (de) Verfahren zur Behandlung von Metalloberflächen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE69834578D1 (de) Verfahren zur behandlung von zementaufschlämmungen
DE60021948D1 (de) Verfahren zur Behandlung von Kontaktlinsen
DE69626311D1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69706758D1 (de) Verfahren zur Behandlung von Polyolefin
DE69609082D1 (de) Verfahren zur behandlung von abfällen
DE69802904D1 (de) Verbessertes verfahren zur behandlung von aluminiummonohydratreichen bauxiten
ATE307871T1 (de) Verfahren zur behandlung von gewebe
DE69905263D1 (de) Verfahren zur dekorativen behandlung von oberflächen
DE69701726D1 (de) Verfahren zur behandlung von knitterempfindlichen geweben
DE60021022D1 (de) Verfahren zur Behandlung von Purinen
DE60034093D1 (de) Verfahren zur Behandlung von Kieselsäuren enthaltenden Schlamm
DE60038642D1 (de) Verfahren zur Behandlung einer Falschdraht-Verwindung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties